Botanical species · safety record

Erysimum cheiranthoides

The EFSA Compendium of Botanicals holds 17 constituent measurements for Erysimum cheiranthoides. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Erysimum cheiranthoides L.

17Constituent measurements
0Safety records
7Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Cardenolides5
  • Erichroside2
  • Olitoriside2
  • Cardiac glycosides1
  • Cheirotoxin1
  • Cymarin1
  • Digitoxigenin1
  • Digitoxin1
  • Erysimoside1
  • Glucosinolates1

Plant parts

  • Unspecified8
  • Aerial part of plants4
  • Seed4
  • Leaves1

Preparations

  • Solvent extraction10

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CardenolidesUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CardenolidesUnspecifiedSolvent extractionUnspecifiedResolve DOI
Cardiac glycosidesSeedResolve DOI
CheirotoxinUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CymarinUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
DigitoxigeninUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
DigitoxinUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
ErysimosideUnspecifiedSolvent extractionUnspecifiedResolve DOI
GlucosinolatesLeavesSolvent extractionGelpermeation, High Performance Thin Layer Chromatography (HPTLC)Resolve DOI
HelveticosideUnspecifiedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
OlitorisideSeedResolve DOI
CardenolidesSeedSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier
CardenolidesAerial part of plants≥ 0.04 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
CardenolidesAerial part of plants≤ 0.55 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
ErichrosideAerial part of plants≥ 0.01 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
ErichrosideAerial part of plants≤ 0.096 PercentGelpermeation, High Performance Thin Layer Chromatography (HPTLC)No resolvable identifier
OlitorisideSeedNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. SACHDEVGUPTA, K., RADKE, CD., RENWICK, JAA., DIMOCK, MB. CARDENOLIDES FROM ERYSIMUM-CHEIRANTHOIDES - FEEDING DETERRENTS TO PIERIS-RAPAE LARVAE. JOURNAL OF CHEMICAL ECOLOGY, 1993, vol. 19, no. 7, p. 1355-1369. DOI
  2. Lei, ZH., Ma, YL., Tai, BS., Jin, ZX., Kong, Q., Yahara, S., Nohara, T. Chemical studies of Erysimum cheiranthoides L. II - Cardenolides from the seeds of Erysimum cheiranthoides. ADVANCES IN PLANT GLYCOSIDES, CHEMISTRY AND BIOLOGY, 1999, vol. 6, p. 403-405.
  3. HUANG, XP., RENWICK, JAA. CARDENOLIDES AS OVIPOSITION DETERRENTS TO 2 PIERIS SPECIES - STRUCTURE-ACTIVITY-RELATIONSHIPS. JOURNAL OF CHEMICAL ECOLOGY, 1994, vol. 20, no. 5, p. 1039-1051. DOI
  4. Vysochina, G. I. Quantitative determination of erichroside and total sum of cardenolides in the overground part of Erysimum cheiranthoides L. by the TLC method . Rastitel'nye resursy, 1998, vol. 34, no. 1, p. 105-110.
  5. Lei, ZH., Kuniyasu, A., Tai, BS., Nakayama, H., Nohara, T. Na+,K+-ATPase inhibiting activity of cardiac glycosides from Erysimum cheiranthoides . Planta medica, 2001, vol. 67, no. 4, p. 369-370. DOI
  6. HUANG, XP., RENWICK, JAA., SACHDEVGUPTA, K. A CHEMICAL BASIS FOR DIFFERENTIAL ACCEPTANCE OF ERYSIMUM-CHEIRANTHOIDES BY 2 PIERIS SPECIES. JOURNAL OF CHEMICAL ECOLOGY, 1993, vol. 19, no. 2, p. 195-210. DOI
  7. Buchvarov, I., Butsev, Kh. Extract of cardenolide glycosides from Erysimum cheiranthoides L. seeds and Convallaria majalis L. leaves. Farmatsiya (sofia, bulgaria), 1976, p. 9-15.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue